Hi-Tech Pharmacal Announces $25M Settlement Regarding Texas Pricing Investigation
December 26, 2013 at 07:01 AM EST
Hi-Tech Pharmacal (NASDAQ: HITK ) today announced that the Texas Attorney General has agreed to close its investigation of Hi-Tech's pricing of products that were purchased with Texas Medicaid dollars. In